Nevro Corp. (NVRO)
NYSE: NVRO · IEX Real-Time Price · USD
8.35
-0.26 (-3.02%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Nevro Revenue

Nevro had revenue of $430.75M in the twelve months ending March 31, 2024, with 3.83% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $101.90M with 5.78% year-over-year growth. In the year 2023, Nevro had annual revenue of $425.17M with 4.63% growth.

Revenue (ttm)
$430.75M
Revenue Growth
+3.83%
P/S Ratio
0.71
Revenue / Employee
$354,523
Employees
1,215
Market Cap
306.68M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023425.17M18.81M4.63%
Dec 31, 2022406.37M19.46M5.03%
Dec 31, 2021386.91M24.86M6.87%
Dec 31, 2020362.05M-28.21M-7.23%
Dec 31, 2019390.26M2.97M0.77%
Dec 31, 2018387.29M60.62M18.56%
Dec 31, 2017326.67M98.17M42.96%
Dec 31, 2016228.50M158.90M228.28%
Dec 31, 201569.61M37.03M113.69%
Dec 31, 201432.57M9.07M38.61%
Dec 31, 201323.50M5.35M29.48%
Dec 31, 201218.15M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 703.37M
OraSure Technologies 304.64M
ADC Therapeutics 68.62M
SOPHiA GENETICS 64.18M
Foghorn Therapeutics 33.90M
C4 Therapeutics 20.04M
Verrica Pharmaceuticals 8.91M
Revenue Rankings